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Infection of epithelial colon carcinoma cell line HT29 with human immunodeficiency virus type 1 (HIV-1) NDK, a subtype
D virus highly cytopathic for CD4-positive lymphocytes, results in the selection of HIV-1 variants, 1000 times more infectious
for CD4 intestinal cells than the parental virus. Here, we demonstrate that the envelope gene of intestinal cell-adapted virus
conferred to recombinant clone HIV-1 iNDK the ability to utilize CXCR4 without CD4 while retaining its tropism for CD4
lymphocytes. Among the major genetic changes required for infection of intestinal cells and CD4 independence, two potential
N-glycosylation sites appeared as a result of the extension of five amino acids in the V1/V2 region and three amino acid
changes (296KYT 3 296NNI) were identified in the V3 loop of HIV-1 iNDK gp120. Our studies suggest that CD4-independentScience (USA)
INTRODUCTION
The entry of human immunodeficiency virus type 1
(HIV-1) into cells normally requires an interaction of en-
velope glycoprotein with the CD4 primary receptor and a
coreceptor from the family of seven-transmembrane
spanning chemokine receptors. Differences in the use of
coreceptors by various HIV-1 isolates in different target
cells elucidated HIV-1 tropism and its changes during
the evolution of disease (Berger et al., 1999). Insight into
the molecular basis of these interactions was obtained
by studies of antibody binding, mutagenesis, and crys-
talography of both receptors and envelope glycoprotein
(Moore et al., 1994; Poignard et al., 1996; Rizzuto et al.,
1998; Wyatt et al., 1998; Wyatt and Sodroski, 1998). Fol-
lowing its binding to CD4, envelope glycoprotein under-
goes conformational changes that involve movements of
the V1/V2 and V3 loops. This allows for formation and/or
the exposure of the bridging sheet that enables gp120 to
bind to a chemokine receptor (Moore et al., 1994; Rizzuto
et al., 1998; Wu et al., 1996; Wyatt and Sodroski, 1998).
While the V1/V2 stem and other gp120 determinants
directly interact with the CD4 molecule, the V3 loop is
principally responsible for specificity of the use of CXCR4
and CCR5 coreceptors (Bieniasz et al., 1997; Choe et al.,
1 Two first authors contributed equally to this work.
2 Present address: Department of Cancer Immunology and AIDS,
Dana-Farber Cancer Institute, Boston, Massachusetts 02115.4031996; Cocchi et al., 1996; Rizzuto et al., 1998; Speck et al.,
1997).
Although CD4 is generally required for efficient inter-
action of gp120 with the coreceptor molecules, some
HIV-1 strains are able to infect CD4-negative cells. It has
been suggested that the conserved chemokine receptor-
binding site is more exposed on gp120 of these viruses
that circumvent the need for conformational changes
induced normally by CD4 (Endres et al., 1996; Kolchinsky
et al., 1999, 2001a; LaBranche et al., 1999). The genetic
determinants for CD4 independence of HIV have been
mapped inside and outside regions required for core-
ceptor specificity. Thus, mutations in or around the V4
loop, in transmembrane protein TM, and in the C3 do-
main of envelope glycoprotein, were found critical for
CXCR4-mediated CD4-independent cell entry of HIV-1
III8x (LaBranche et al., 1999) and HIV-2 LAV2B (Reeves
and Schulz, 1997). Different mutations present in the C2
and C3 regions, and the V3 loop, render HIV-1 m7NDK
capable to fuse with CD4-negative cells in the presence
of CXCR4 (Dumonceaux et al., 1998). In all these cases,
CD4 independence has been related to the modification
of the N-glycosylation profile. Specifically, a single mu-
tation in V1/V2 region of primary isolate ADA resulting in
the loss of a glycosylation site was shown to be respon-
sible for CD4-independent CCR5-mediated cell fusion
(Kolchinsky et al., 1999, 2001a). In contrast, the acquisi-
tion of a potential N-glycosylation site in the C2 region of
gp120 has been essential for determination of the CD4-use of CXCR4 can be mediated by different adaptive chan
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In this article, we describe genetic adaptation of HIV-1
NDK in the colon carcinoma epithelial cell line HT29.
This line expresses a truncated CD4 molecule recog-
nized by 13B8.2 and B14 but not by HIV-blocking OKT4A
and Leu3A mAb. Therefore, it lacks the binding site for
HIV-1 gp120 (Fantini et al., 1991). In addition, it coex-
presses galactosylceramide, a potential alternative HIV-1
receptor (Fantini et al., 1993; Yahi et al., 1992), together
with CXCR4 on its surface (Delezay et al., 1997). Results
from several laboratories show that HIV-1 uses galacto-
ceramide as an alternative receptor to CD4 to enter HT29
cells (Bomsel, 1997; Fantini et al., 1991, 1993). Of a dozen
virus isolates, only HIV-1 NDK, the Zairian subtype D virus
highly cytopathic for CD4 lymphocytes (Ellrodt et al., 1984;
Hirsch et al., 1990; Spire et al., 1989, 1990), was able to
chronically infect HT29 cells (Fantini et al., 1991, 1992) and
some other CD4-negative cell lines (Brichacek et al., 1992).
We have recently shown that infection of HT29 cells
with HIV-1 NDK results in the selection of HIV-1 variants
1000 times more infectious for HT29 cells and primary
fetal enterocytes than the parental virus (Chenine et al.,
1998). Here we found that a recombinant molecular clone
named HIV-1 iNDK, containing envelope glycoprotein of
intestinal cell-adapted virus, acquired the ability to utilize
CXCR4 without CD4 and retained its tropism for CD4
lymphocytes. The major genetic changes responsible for
intestinal cell-adapted and CD4-independent phenotype
mapped to the C1, V1–V4 hypervariable loops of gp120
and in gp41. Among them, two potential N-glycosylation
sites were acquired in the V1/V2 region and one N-
glycosylation site was lost from V4 region, confirming the
importance of total N-glycosylation profile for infectivity
of intestinal cells. Acquisition of potential N-glycosylation
sites in the V1/V2 region contrasts with their loss in some
other CD4-independent HIV-1 strains (Kolchinsky et al.,
1999, 2001a). Three amino acid changes (296KYT3 296NNI)
were identified in the V3 loop of HIV-1 iNDK gp120. Our
data suggest that the adaptation process in CD4, galac-
tosylceramide intestinal cells consisted of selection of
variants of noncloned parental HIV-1 NDK, propagated in
T lymphocytes, that contained the extension of the V1/V2
region. This was followed by genetic shift in the V3 loop.
The amino acid sequence of HIV-1 iNDK significantly
differs from the sequence of another CD4-independent
variant HIV-1 m7NDK selected from the same parental
virus in the T lymphoid cell line CEM (Dumonceaux et al.,
1998, 2001). This demonstrates that different viral genomes
are selected in CD4 epithelial intestinal cells vs T lympho-
cytes, but both can mediate CD4-independence.
RESULTS
Chronic infection of intestinal cells line HT29 with
HIV-1 NDK
We found that during approximately 60 days postinfec-
tion (p.i.) with a noncloned HIV-1 NDK stock prepared in
PBL lymphocytes (HIV-1 NDKPBL), viral production dou-
bled each 17 days (Fig. 1A). This initial period of slow
virus replication was followed by a second phase of
infection during which the virus production doubled each
7 days. Virus production reached a plateau at 90 days
postinfection (p.i.) and remained stable during the course
of an 8-month culture. The virus produced by HT29 cells
120 days p.i., called HIV-1 NDKHT29, replicated in fresh
HT29 cells immediately, with a growth rate indistinguish-
able from that reached during the second phase of HT29
infection with HIV-1 NDKPBL.
Only a fraction of the persistently infected population
contains HIV-1 provirus
The HIV-1 genome was expressed in approximately
15% of HT29 cells at the plateau of virus production (120
days p.i. with HIV-1 NDKPBL) as analyzed by HIV-1 RNA in
situ hybridization in mock-infected and infected cells
(Figs. 1B and 1C). A similar proportion of HIV-1-positive
cells was determined by coculture (9%, Table 1) and by
PCR (11%, not shown) of limiting cell dilutions.
To test the stability of the pool of HIV-1-positive cells,
the persistently infected steady-state culture was treated
with azidothymidine (AZT). AZT blocks de novo infection
of cells and their recruitment into the HIV-1-positive pool
but permits virus production from previously infected
cells. Virus production was reduced approximately 10-
fold by continuous cultivation in the presence of 50 M
FIG. 1. Adaptation of HIV-1 NDK in intestinal cells. (A) HT29 cells
(2.5  106) in 25-cm2 flasks were infected in parallel with 1 g of p24gag
of HIV-1 NDKPBL () and HIV-1 NDKHT29 (). Virus stocks were prepared
in PBL (HIV-1 NDKPBL) and in HT29 cells (HIV-1 NDKHT29, harvested 120
days p.i. as indicated by the arrow). An aliquot of HT29 culture infected
with HIV-1 NDKPBL was treated with 50 M AZT starting at day 120 p.i.
(F). Cells were split each 3 or 4 days in a ratio of 1:6. The lines
represent slopes used to estimate growth rates at various times after
culture. (B, C) In situ hybridization of HIV-1 RNA in HIV-1 NDKHT29
mock-infected (B) and infected (C) HT29 cells 120 days p.i.
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AZT for 50 days (Fig. 1A). During the same time, the
number of infectious centers was reduced ninefold, from
9 to 1% of the total HT29 population (not shown), indicat-
ing that HIV-1 production is proportional to the concen-
tration of HIV-1-infected cells. This indicates that de novo
infection is necessary to sustain steady-state levels of
HIV-1-infected cells.
Derivation of cell clones from a persistently infected
culture
Individual cells from the persistently infected steady-
state culture were cloned by limiting dilution at 120 days
p.i. (Table 1). HIV-1 production was detected in 7 of 55
(13%) clones. The 13% frequency of HIV-1-producing
clones matches well the 15 and 9% frequency of HIV-1-
infected cells determined by in situ hybridization (Fig. 1)
and by infectious centers technique (Table 1), respec-
tively. The HIV-1 provirus was uniformly rescued from all
progeny cells in the four clones, HT29A4, HT29F7, HT29E10,
and HT29C9. The three other clones were lost. These
HIV-1-positive clones produced 5 to 12 times more p24gag
than the original persistently infected culture, consistent
with the production of HIV-1 provirus by the majority of
the cloned cell population. Noncloned HIV-1 NDKHT29 and
the viruses produced by all four clones were highly
cytopathic for MT4 cells and showed similar values of
infectious titers determined in PBL lymphocytes and nor-
malized to p24gag titers as those determined for paren-
tal virus HIV-1 NDKPBL (not shown). However, the ratio of
infectious titers determined in HT29 cells and PBL lym-
phocytes was about 1000 times higher for HT29 cell-
adapted viruses than for parental HIV-1 NDKPBL virus.
Thus, the viruses adapted to intestinal cells while keep-
ing their high tropism for T lymphocytes (Table 1).
The generation times of some clones containing a
stable HIV-1 provirus (HT29A4 and HT29F7) were signifi-
cantly prolonged in comparison with noninfected cells
without changes in the viabilities of these cultures (Table 1).
Reduced growth rate of some HIV-1-producing clones is in
agreement with gradual loss of HIV-1-infected HT29 cells in
the presence of AZT (Fig. 1A). It also suggests that virus
replication induces cytotoxic effects in HT29 cells, without
apparent cytopathic effects visible by optical microscopy.
Envelope gene-containing fragment confers
the intestinal cell-adapted phenotype
to recombinant virus
We addressed the question of whether the adaptation
to intestinal cells, similar to in previously described CD4-
independent viruses (Dumonceaux et al., 1998, 2001;
Endres et al., 1996; Kolchinsky et al., 1999, 2001a; La-
Branche et al., 1999), is related to properties of envelope
glycoprotein. To this end, the env-containing EcoRI5734-
XhoI8857 fragments of HIV-1 proviruses harbored in cell
clones HT29A4 and HT29C9 were cloned in pBluescript
vector and exchanged with homologous fragments of
pNL4-3. Recombinant viruses were prepared by trans-
fection of HeLa cells and their growth properties in HT29
were compared with those of the intestinal cell-adapted
prototype virus HIV-1 NDKA4 (Chenine et al., 1998) pro-
duced by cell clone HT29A4 (Fig. 2). A molecular clone
named iNDK, constructed by cloning envelop glycopro-
teins from HT29C9 cell clone, replicated with the charac-
teristics of HIV-1 NDKA4. Molecular clones HIV-1 NL4-3
and HIV-1 NDK (Spire et al., 1989) did not produce any
significant amount of virus.
Another recombinant HIV-1 CB4 derived from the cell
clone HT29A4 produced 1000 times less virus than HIV-1
iNDK at 8 days p.i. However, it reached HIV-1 iNDK
production level after 32 days of the cell growth. This
suggests that secondary adaptation changes occurred in
the genome of HIV-1 CB4 after infection of intestinal
TABLE 1
Cloning of Persistently Infected HT29 Cellsa
HT29 cells
p24gag
(ng/ml)b
Infectious centers
(%)c MT4 cped
Adaptation for HT29 cells
(fold)e
Generation time
(h)
Mock infected cells 0 0.001 18.0 2.1
Uncloned HT29 340 9  470 18.7 2.0
Clone HT29A4 4230 100  1000 28.8 2.0
Clone HT29F7 2000 100  1000 23.5 2.1
Clone HT29E10 2732 100  1000 18.0 2.0
Clone HT29C9 1800 100  1000 17.0 1.4
a Persistently infected culture of HT29 cells 120 days p.i. with HIV-1 NDK was cloned by sublimit dilution. HIV-1 producing clones were further
expanded and analyzed 8 weeks later, i.e., 190 days p.i.
b Virus concentrations in cell supernatants were determined by the p24gag-antigen capture technique.
c Determined by statistical analysis of eight parallel end point dilution assays of trypsinized culture as measured by cocultivation with MT4
lymphocytes and syncytia formation. Positive cut-off value represented 0.001% of the total cell population.
d cpe, cytopathic effect; , large NDK-like syncytia.
e The titer ratio of HT29 cell-adapted virus to parental HIV-1 NDKPBL as determined in HT29 cells after normalization for infectivity in PBL
(TCIDHT29/TCIDPBL value determined for HT29-adapted virus to that of HIV-1 NDKPBL).
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cells. The production of another HT29A4-derived HIV-1
CB2 did not reach HIV-1 iNDK production level during the
32-day observation period. These results indicate that
envelope glycoproteins are able to confer an intestinal
cell-adapted phenotype to recombinant virus.
Sequence analysis of envelope glycoproteins of
intestinal cell-adapted viruses
Altogether 27 amino acid changes were detected in
HIV-1 iNDK envelope glycoprotein in comparison with
the published sequence of molecular clone HIV-1 NDK
(Spire et al., 1989): 18 changes were localized in gp120
and 9 were localized in gp41 (Fig. 3). Insertions of 139T
and of another four amino acids coupled with substitu-
tion of one amino acid, 156ITTAL, were determined in the
variable loops V1/V2 of gp120. Both insertions resulted in
the formation of potential N-glycosylation sites. In addi-
tion to the changes in the V1/V2 region, substitution
K329N at the very beginning of C3 region also results in
the formation of additional N-glycosylation sites. One of
five N-glycosylation sites in the V4 region of gp120 was
deleted in HIV-1 iNDK by substitution N401I. In HIV-1
CB4, another amino acid substitution in the V4 region
(N392D), different from that in HIV-1 NDK, resulted also in
the loss of a potential N-glycosylation site. The only
substitution detected in the V3 region of iNDK, 296KYT3
296NNI, is identical to one of the changes of CD4-inde-
pendent virus HIV-1 m7NDK (Dumonceaux et al., 1998),
selected from the same parental virus as HIV-1 iNDK in
the T lymphoid cell line CEM. Identical amino acid se-
quences of V1/V2, C2, and V3 regions were determined
for molecular clone iNDK and for the major sequence of
HIV-1 NDKHT29 noncloned virus harvested 120 days p.i. of
HT29 cells.
Genetic shift in gp120 is a part of the adaptation
process
The most striking change accompanying increasing
growing rate of molecular clone HIV-1 CB4 during its
cultivation in intestinal cells (Fig. 2) was a sequence shift
in the V3 loop of gp120 (Fig. 3). The major sequence of
the virus called HIV-1 CB4ad was determined at 32 days
p.i. of HT29 cells with molecular clone HIV-1 CB4 when it
approached the replication rate of HIV-1 iNDK. It showed
four amino acid changes, A276V, 296KYT 3 296NNI, in
comparison with the parental molecular clone HIV-1 CB4,
all identical to those observed in HIV-1 iNDK. One addi-
tional mutation Q308P different from iNDK developed
during the adaptation process. Proline appeared at the
top of V3 region as in GPGR motif present in the majority
of subtype B viruses. The amino acid substitution N392D,
specific for HIV-1 CB4, resulting in the loss of potential
N-glycosylation site in the V4 region was conserved in
HIV-1 CB4ad. Thus, reduced glycosylation of V4 region
seems to be important for the adaptation process in
intestinal cells.
Extension of the V1/V2 variable region is present in
HIV-1 iNDK prepared in T lymphocytes
Some of the 27 amino acid changes detected in the
envelope glycoprotein of HIV-1 iNDK in comparison with
molecular clone HIV-1 NDK were identical to changes
present in the major sequence of parental HIV-1 NDKPBL
(I83L, K329N, L372F, R385K, F399L H540Q, R547T,
R578K). Conceivably, these mutations were not gener-
ated during the adaptation period but were selected from
HIV-1 NDKPBL stock. We addressed a question whether
the insertion 156ITTAL found in HIV-1 iNDK was also
present already in the original noncloned stock of HIV-1
NDKPBL, although it was absent in its major sequence.
Insertion of 12 nucleotides in the V1/V2 region of gp120
of HIV-1 iNDK was used to design PCR primers to test
the presence of nucleotide sequence coding for V1/V2
extension in the stock of HIV-1 NDKPBL (Fig. 4). Primer
pairs v2/ron1 and v2/pa amplified respective se-
quences of plasmid piNDK DNA. The same primer pairs
failed to yield an amplification product when genomic
DNA extracted from the HIV-1 NDKPBL-infected PBL was
assayed. Using PCR primers polA1 and nef followed by
nested PCR using primer pairs pa/v2 and v2/ron1,
HIV-1 NDKPBL-infected PBL DNA showed the same am-
plification product as piNDK. Thus positive signal in
nested PCR indicates that viruses with the V2 extension
are present in the stock of HIV-1 NDKPBL. The absence of
FIG. 2. Replication of molecular clones of HIV-1 containing envelope
glycoprotein from cell clones infected with intestinal cell-adapted virus.
pBluescript-cloned fragments EcoRI5734-XhoI8857 of HIV-1 DNA from cell
clones HT29A4 and HT29C9 (Table 1) were subcloned into homologous
sites of pNL4-3. Molecular clones CB2 and CB4 (derived from cell clone
HT29A4), iNDK (derived from cell clone HT29C9), and control viruses
HIV-1 NL4-3 and HIV-1 NDK were transfected into HeLa. HIV-1 NDKA4 is
a virus produced by cell clone HT29A4 characterized in our previous
study (Chenine et al., 1998). Infection of HT29 cells with 10 ng of p24gag
of resulting viruses per 106 cells was monitored by the production of
p24gag. The p24gag values represent the virus production accumulated
after 3 or 4 days cultivation period, at the time when the cells were split
in a ratio of 1:6.
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the insertion 156ITTAL in the major sequence of the pa-
rental noncloned virus HIV-1 NDKPBL and the lack of the
amplification product in the first round of PCR suggest
that viruses containing the V2 extension form a minor
fraction in HIV-1 NDKPBL.
Mapping of intestinal cell-adapted phenotype using
viruses recombinant in env gene
Infection of intestinal cells with molecular clone HIV-1
NDK results in transient virus production (De Mareuil et
al., 1995) without virus adaptation and persistence (Fig.
2). We have shown previously that this transient produc-
tion is genetically controlled by the gag-pol region of the
HIV-1 genome (De Mareuil et al., 1995). No virus has
been produced after infection with recombinant HIV-1
NLDE bearing HIV-1 NL4-3-derived gag-pol region (Fig.
5) (De Mareuil et al., 1995).
To identify the determinants of intestinal cell-adapted
phenotype in env gene, a set of reciprocal chimeras was
generated between molecular clone HIV-1 NLDE (Spire
FIG. 3. Amino acid sequence of the envelope gene of intestinal cell-adapted viruses. The Env sequence of molecular clone HIV-1 NDK (Spire et
al., 1989) was compared with the Env sequences of HIV-1 iNDK, HIV-1 CB4, as well as with the major sequence of HIV-1 NDKPBL, with a part of the
major sequence of HIV-1 NDKHT29, and with the major sequence of HIV-1 CB4ad, determined after full adaptation of HIV-1 CB4 in intestinal cells. The
major sequences of HIV-1 NDKPBL, HIV-1 NDKHT29, and HIV-1 CB4ad were determined after amplification of genomic DNA extracted from infected cells
by primers polA1/nef. Predicted N-glycosylation sites are shown by asterisks. msd, the TM membrane-spanning domain. Numbers in prototype
sequence correspond to nucleotide positions in the HIV-1 NDK sequence (Spire et al., 1989).
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et al., 1990) and HIV-1 iNDK. Both parental clones and
recombinants beared envelope genes inserted into the
context of HIV-1 NL4-3 and replicated in reference cell
line HeLa CD4. Unique restriction sites were used to
isolate and characterize mutations in subdomains of
gp120. Replication of all recombinants was inferior to
that of parental clone iNDK. The minimal region neces-
sary to confer to the recombinants the intestinal cell-
adapted phenotype comprised the 5 half of iNDK env
gene up to ClaI7120 site (recombinant MCE). This fragment
contains insertions 139T and 156ITTAL in the V1/V2 region
and substitution 296KYT 3 296NNI in the V3 region of
gp120. The capacity to replicate in intestinal cells was
lost following the replacement of the V3 region of iNDK
gp120 in recombinant HIV-1 K23 with the prototype se-
quence. Also recombinant MCEB, containing the V3 re-
gion as the only iNDK-derived sequence, did not repli-
cate in our test system, suggesting that the V3 hyper-
variable loop is necessary but not sufficient for infection
of intestinal cells and the CD4-independent phenotype.
Specific infectivity of recombinants was augmented by
the presence of additional mutations localized in C1, C3,
and gp41 regions of env (recombinant KC9P) and in the rest
of env gene (recombinant iNDK). This shows that the entire
env gene contributes to adaptation in intestinal cells.
Surprisingly, iNDK fragment BglII7016/BglII8033 (recombi-
nant KEXB) containing the V3 and V4 regions of the HIV-1
iNDK gp120 conferred HIV-1 NLDE weak but reproduc-
ible capacity to replicate in HT29 cells. This indicates
that the lack of the extension of the V1/V2 region can be
complemented by amino acid changes in V3, C3, and V4
of gp120 and at the N-terminus of gp41, although the
virus replication was weak in this case. Presumably,
KEXB recombinant-like virus has a very low probability to
emerge during infection of intestinal cells with parental
HIV-1 NDKPBL virus. However, once constructed in vitro,
KEXB virus replicates in intestinal cells.
Envelope glycoprotein but not vpu, tat, and rev genes
of HIV-1 iNDK are necessary for adaptation in
intestinal cells
In addition to the env gene, complete vpu, tat, and rev
genes were imported within the EcoRI5734-XhoI8857 frag-
FIG. 4. Extension of V2 region of gp120 is present in noncloned
parental HIV-1 NDKPBL prepared in T lymphocytes. (A) Design of ampli-
fication primers comprising the insertion of 12 nucleotides and the
transition of 1 nucleotide in V2 region of gp120, responsible for the
insertion 156ITTAL. Mutated nucleotides and amino acids are high-
lighted by bold characters. Schematic position and orientation of prim-
ers and nested primers are shown by arrows. (B) Amplification of
piNDK (a), genomic DNA extracted from HIV-1 NDKPBL infected PBL (b),
and pNDK (Spire et al., 1989) (c) by nested PCR using polA1 and nef
primers in primary reaction and nested primer pairs pa/v2 and v2/ron1
are shown. Migration in agarose gel visualized by ethidium bromide.
FIG. 5. Productive infection of HT29 and HeLa cells by chimeric viruses. (A) Recombinant provirus molecules derived from molecular clones HIV-1
NLDE (Spire et al., 1990) and HIV-1 iNDK were constructed using conserved restriction sites indicated by arrows. Mutations and cloned portion of
HIV-1 iNDK and HIV-1 NDK genome are shown in bold and normal characters and full and pointed lines, respectively. FP, fusion peptide; TM,
transmembrane domain. (B) Total of 2  105 cells were infected with 100 ng of p24gag of input virus and HIV-1 production determined 5 days p.i. —,
10 pg of p24gag/ml, the sensitivity level of p24gag assay.
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ment into HIV-1 iNDK. Several amino acid changes were
detected in Vpu (R31L, G54D), Tat (S10P), and Rev (N26D,
the first exon and F63L, the second exon) genes of HIV-1
iNDK with respect to the standard HIV-1 NDK sequence.
Except for the Tat (S10P) mutation present in consensus
sequence of subtype D tat gene, the other mutations are
rare in HIV sequence database. All of them could poten-
tially be important for replication of HIV-1 iNDK in intes-
tinal cells. However, the higher infectivity of HIV-1 KEXB,
which contains HIV-1 NL4-3-derived vpu, tat, and rev
genes, in comparison with HIV-1 K23 containing the
same genes derived from HIV-1 iNDK (Fig. 5), indicates
that these sequences are not responsible for the intes-
tinal cell-adapted phenotype.
HIV-1 iNDK is CD4-independent and CXCR4-tropic
The efficiency of HIV-1 recombinants to replicate in
HT29 cells correlated with infection of CD4, CXCR4
HeLa cells (Fig. 5). This suggests that HIV-1 iNDK can
enter the cell by CD4-independent mechanism using
CXCR4 coreceptor. It was previously shown that infection
of HT29 cells by parental strain HIV-1 NDK is mediated
by CXCR4 and galactoceramide receptors and is insen-
sitive to treatment of HT29 cells with anti-CD4 antibodies
(Bomsel, 1997; Fantini et al., 1991, 1993).
All tested recombinants likely retained the ability to
bind to CD4 as evidenced by their increased ability to
infect CD4 relative to CD4 HeLa cells (Fig. 5). The
CXCR4-tropic character of intestinal cell-adapted virus
HIV-1 iNDK as well as of uncloned HIV-1 NDKA4 was
confirmed by productive infection of CXCR4 but not of
CCR5 CD4 U87 cells (Fig. 6). As expected, the control
R5-tropic virus HIV-1 JRFL infected CCR5, but not
CXCR4 CD4 U87 cells. Infection of CD4 HeLa cells
with HIV-1 iNDK was highly sensitive to treatment with
anti-CD4 (Q4120) and anti-CXCR4 (12G5) antibody (Fig.
7A), similar to the case of CD4-independent viruses de-
scribed previously in other laboratories (Dumonceaux et
al., 1998; LaBranche et al., 1999). The residual HIV-1
iNDK production after the treatment of CD4 HeLa cells
with Q4120 anti-CD4 mAb corresponded well to virus
production by CD4 HeLa cells (0.22 and 0.1 ng of p24gag
per milliliter of cell-free supernatant at 5 days p.i., re-
spectively; Fig. 7B). Surprisingly, the treatment of CD4
HeLa cells with 12G5 anti-CXCR4 mAb resulted in po-
tentiation (160%) of HIV-1 iNDK production in three
independent experiments. This suggests that 12G5 anti-
CXCR4 mAb renders CXCR4 coreceptor more suitable
for direct interaction with HIV-1 iNDK gp120 during
CD4-independent virus-cell entry. In contrast 12G5 in-
hibits this interaction when gp120 reacts with CXCR4
in a sequential manner after conformational change
by previous contact with CD4 molecule in CD4 HeLa
cells (Fig. 7A). In HT29 cells expressing CXCR4 (Delezay
et al., 1997), anti-CXCR4 mAb inhibited significantly, al-
though incompletely, infection of HT29 cells with HIV-1
iNDK (Fig. 7C). An increased inhibitory effect on replica-
tion of HIV-1 iNDK in comparison with 12G5 was
achieved by SDF-1, the natural ligand of CXCR4 receptor,
suggesting that HIV-1 iNDK uses this molecule for its
entry into HT29 cell.
FIG. 6. Infection of CD4 U87 cells expressing CCR5 or CXCR4
coreceptor with HIV-1 JRFL, NDKA4, and iNDK. HIV-1 JRFL is a control
R5-tropic virus. HIV-1 NDKA4 is uncloned virus produced by cell clone
HT29A4 (Table 1).
FIG. 7. Inhibition of HIV-1 replication by mAb against CD4 (Q4120) and CXCR4 (12G5) receptors and by SDF-1, the natural ligand of CXCR4 receptor,
in HeLa-CD4 (A), HeLa (B), and HT29 (C) cells. The cell monolayers (106 cells) were incubated with blocking agents for 30 min before and then during
2 h adsorption of 500 ng of p24gag of HIV-1 NL4-3, NDKPBL, and iNDK at 4°C. After virus adsorption, the cells were washed, trypsinized, and washed
again. Virus production was determined at 5 days p.i. The numbers at the top of the columns are percentages of HIV-1 production by untreated virus.
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DISCUSSION
The present study shows that a long-term culture of
HT29 cells infected with HIV-1 NDK results in the selec-
tion of HIV-1 variants highly infectious for HT29 cells and
primary fetal enterocytes (Chenine et al., 1998). The N-
terminal part of the envelope glycoprotein of intestinal
cell-adapted viral clone HIV-1 iNDK, including the V3
hypervariable loop, conferred to recombinants the ability
to utilize CXCR4 in the absence of CD4 without losing its
tropism for the CD4 T lymphocytes. The major changes
found in the intestinal cell-adapted virus have occurred
in the V1/V2 and V3 hypervariable loops of the envelope
glycoprotein, the regions implicated in the cooperative
interaction with the coreceptor of HIV-1 (Jones et al.,
1998; Moore et al., 1994; Wu et al., 1996; Wyatt and
Sodroski, 1998). Further studies will be necessary to
demonstrate exactly which change mediates this pheno-
type. Changes in these regions are generally necessary
for CD4-independent cell entry also in other HIV-1 iso-
lates (Dumonceaux et al., 1998; Endres et al., 1996;
Kolchinsky et al., 1999, 2001a; LaBranche et al., 1999).
These changes occurred despite the presence of galac-
tosylceramide, a potential alternative gp120 receptor
molecule, on the surface of HT29 cells (Fantini et al.,
1993; Yahi et al., 1992).
An additional potential N-glycosylation site localized in
the V1/V2 loop at the position aligned with the sequence
156ITTAL of HIV-1 iNDK appeared in the virus isolated
from the original blood donor of the Sydney Blood Bank
Cohort, concomitantly with development of AIDS 18
years after infection with nef-deleted HIV-1 strain (Jekle
et al., 2002). The virus obtained at the onset of disease
was more cytotoxic than the earlier isolate and the in-
creased cytotoxicity was caused by more efficient
CXCR4 usage and expanded target cell range.
Whereas the loss of a single potential N-glycosylation
site in V1/V2 variable region of a primary R5 HIV-1 isolate
ADA is sufficient for CD4-independent replication
(Kolchinsky et al., 1999, 2001a), more complex changes
of N-glycosylation profile are responsible for CD4-inde-
pendent replication of other viruses (Fig. 8) (Dumon-
ceaux et al., 2001; Endres et al., 1996; LaBranche et al.,
1999). In HIV-1 iNDK, two potential N-glycosylation sites
have been acquired in the V1/V2 region, thus approach-
ing potential N-glycosylation profile observed in the CD4-
independent variant HIV-1 ADA197N/S. Both viruses
lacked a potential N-glycosylation site at the N-terminus
of the C2 region, sufficient for CD4 independence of
HIV-1 ADA-P (Fig. 8, amino acid 192 of the NDK prototype
sequence). We assume that analogically to the interac-
tion of HIV-1 ADA-P to CCR5 (Kolchinsky et al., 2001a),
N-glycosylation profile can alter the steric position of the
V1/V2 variable loops of HIV-1 iNDK facilitating the bind-
ing of gp120 to CXCR4.
All changes characteristic for the HIV-1 iNDK V1/V2
region are absent in HIV-1 m7NDK, another CD4-inde-
pendent variant derived by the selection of the same
parental virus in CEM T lymphocytes. Moreover, the
potential N-glycosylation site (D192N) essential for CD4-
independent phenotype of HIV-1 m7NDK present at the
N-terminus of the C2 region of HIV-1 m7NDK gp120
(Dumonceaux et al., 1998, 2001) is absent in HIV-1 iNDK.
The acquisition of additional potential N-glycosylation
sites at different positions of HIV-1 iNDK and m7NDK
gp120 may compensate for the weak glycosylation of the
V1/V2 region of the prototype HIV-1 NDK gp120 and can
stabilize the open conformation of the CXCR4 coreceptor
binding site. Adaptation in CD4 cells seems to be ac-
companied by acquisition of potential N-glycosylation
sites in the weakly glycosylated T cell line-adapted virus
HIV-1 NDKPBL. In contrast, potential N-glycosylation sites
are lost from heavily glycosylated CCR5-using primary
isolate HIV-1 ADA and CXCR4-using HIV-1 III8x (molec-
ular clones ADA197N/S and HXBC2 (8x), Fig. 8).
Amino acid changes in the V4 region of gp120 and
gp41 substantially increased infectivity for CD4-negative
cells and were able to compensate for the lack of
changes in the V1/V2 regions of gp120. Similar to in
HIV-1 III8x, the V4 region has been clearly involved in
CD4 independence of HIV-1 iNDK. One glycosylation site
FIG. 8. Comparison of amino acid sequences of the V1/V2 region of envelope glycoproteins involved in CD4-independent cell fusion. Potential
glycosylation sites are shown by asterisks. (E) Glycosylation sites that were not present in prototype sequences but were acquired in CD4-
independent variants are marked by asterisks placed into open circles. () Glycosylation sites that were lost from the prototype sequence of AD8
(Kolchinsky et al., 1999, 2001a) and HXBC2 (LaBranche et al., 1999) resulting in CD4-independent phenotype are shown by open squares. Amino acid
symbols that changed in CD4-independent variants of HIV-1 ADA and HXBC2 are shadowed.
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was lost in this loop. The steric proximity of the V3 and V4
regions of HIV-1 gp120 (Wyatt et al., 1998; Wyatt and
Sodroski, 1998) suggests that both variable loops can
cooperate with CXCR4 in CD4-independent entry.
Three amino acid changes (296KYT 3 296NNI) present
in the V3 loop of intestinal cell-adapted virus HIV-1 iNDK
correlated with replication of tested recombinants in in-
testinal and CD4 HeLa cells. Our results suggest that
these mutations are necessary but not sufficient for CD4-
independent phenotype. The loss of one positive charge
(K296N) and increased hydrophobicity (T298I) of V3 loop
may be a part of the general mechanism that augments
direct interaction of gp120 with CXCR4. The importance
of these changes for adaptation in intestinal cells and for
a CD4-independent phenotype is further highlighted by
their appearance in the major sequence of HIV-1 CB4ad,
following the full adaptation and genetic shift of molec-
ular clone HIV-1 CB4 (Fig. 3).
Amino acid changes 296KYT 3 296NNI are the only
common changes present in both HIV-1 iNDK and
m7NDK. Mutations in the C2 and C3 region of gp120
observed in HIV-1 m7NDK have not been found in HIV-1
iNDK, and inversely, other changes present in HIV-1
iNDK were not found in HIV-1 m7NDK. Taken together,
the amino acid sequence of the HIV-1 iNDK envelope
glycoproteins differs substantially from that of the CD4-
independent variant HIV-1 m7NDK, showing that signifi-
cantly different genetic changes related to a similar CD4-
independent phenotype have been selected in epithelial
intestinal cells vs T lymphocytes.
Two evolutionary mechanisms were observed during
the course of the adaptation of HIV-1 NDK in intestinal
cells: Initially, variants preexisting in the viral population,
propagated in CD4 T cells (e.g., HIV-1 CB2 and HIV-1
CB4), were selected in intestinal cells and underwent
low-level replication. During this phase, genetic shift
occurred in some selected variants, resulting in viruses
(e.g., HIV-1 CB4ad) capable of high levels of replication.
These viruses established chronic infection of CD4
intestinal epithelial cells. Constant presence of the V1/V2
extension in molecular clones obtained from HT29 cells
harboring adapted virus and in the major sequence of
HIV-1 NDKHT29, together with its presence in the stock of
parental HIV-1 NDKPBL, suggests that it is a prerequisite
for infection of intestinal cells. It can enable the initial
virus replication, thus permitting genetic shift in the V3
region followed by further increase of replication rate.
Extension of the V1/V2 loop, observed in HIV-1 iNDK, is
frequently present among other HIV-1 viruses (Fig. 8).
Conceivably, the V1/V2 extension could be present in
HIV-1 NDK primary isolate but being dispensable for
HIV-1 replication in T cell lines it was deleted from the
majority of viral populations during the years of lasting
cultivation in vitro.
The exposure of highly conservative receptor-binding
domains in CD4-activated HIV-1 envelope glycoprotein
elicited the generation of a potent and broadly cross-
neutralizing antibody in immunized mice (LaCasse et al.,
1999). The conserved chemokine receptor-binding site is
more exposed on the surface antigen of CD4-indepen-
dent HIV-1 viruses that are also more sensitive to neu-
tralization by mAb reactive with CD4-induced epitopes
(Hoffman et al., 1999; Kolchinsky et al., 2001b). Two re-
cent studies demonstrated that combination of mAb
raised against conservative epitopes of gp120 including
CD4 receptor-binding site is able to confer sterilizing
immunity against lentiviral infection (Baba et al., 2000;
Mascola et al., 2000). Envelope glycoprotein prepared
from CD4-independent viruses is thus interesting as a
potential immunogen for future vaccination studies.
MATERIALS AND METHODS
Viruses and tissue culture
Highly cytopathic HIV-1 NDK (Ellrodt et al., 1984) was
propagated in primary blood lymphocytes (PBL). Briefly,
peripheral blood mononuclear cells (PBMC) of healthy
donors separated on Ficoll–Hypaque gradients and de-
pleted of monocytes by adherence to a plastic culture
flask were activated with phytohemagglutinin (PHA)-P
(Difco, Franklin Lakes, NJ) at 2 g/ml in RPMI 1640
supplemented with 200 U/ml recombinant interleukin-2
(IL-2, Chiron), 15% fetal calf serum (FCS), and antibiotics
for a period of 3 days. T cells were then infected with
HIV-1 NDK at a multiplicity of infection (m.o.i.) of 0.01
tissue culture infectious doses (TCID) per cell. All viral
stocks were treated with 200 U DNaseI/ml for 30 min at
room temperature before use. HT29 purchased from
ATCC (ATCC HTB38) is a human colonic epithelial cell
line. MT4 and C8166 are immortalized CD4 T cell lines.
They were cultivated as described earlier (Fantini et al.,
1991; Rey et al., 1991). HeLa is a CD4 human epithelial
cell line and HeLa P4 is a stably transfected HeLa cell
line which express CD4.
HIV-1 growth and infectivity assays
Virus concentrations in cell supernatants were de-
termined by reverse transcriptase (RT) assay (Barre-
Sinoussi et al., 1983) and by the p24gag-antigen capture
technique (Coulter Inc., Hialeah, FL, HIV-1 p24 Antigen
Assay). Virus titer, expressed as tissue culture infectious
dose TCIUMT4, was determined in an end-point dilution
assay as measured by RT activity and formation of syn-
cytia in MT4 cells. Reverse transcription of HIV-1
genomic RNA was also monitored by PCR. Cell lysates
were prepared and the amplification reaction was car-
ried out as described previously (Schmidtmayerova et al.,
1992). Intermediate gag primers (Sauvaigo et al., 1993)
were localized at the following positions in HIV-1 LAV
sequence: gag  primer A1 (882–909), gag  primer A2
(1177–1204), gag probe CBIO (949–976).
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In situ hybridization of HIV-1-specific RNA
Infected HT29 cells cultured on chamber slides (Nunc)
were fixed with 4% paraformaldehyde and in situ hybrid-
ization of HIV-1 RNA was performed as described earlier
(Schmidtmayerova et al., 1992). Quantity of cells express-
ing HIV-1 RNA was measured directly by in situ hybrid-
ization as a proportion of cells in the tissue culture
monolayer exhibiting a positive signal visible with an
optical microscope.
Quantitation of HIV-1-infected cells
The quantity of cells containing HIV-1 DNA or rescu-
able virus was determined by PCR or by cocultivation
with MT4 cells, respectively. Infected HT29 cells were
washed twice with trypsin–EDTA and twice with PBS,
and 12 series of 10-fold dilutions of resuspended HT29
cells were carried out in parallel in 96-well microtiter
plates. Infectious centers were determined as described
by Rey et al. (1991) in modification for adherent cells (De
Mareuil et al., 1995). Cell lysates for quantitation of HIV-1
DNA by PCR were prepared 5 days after trypsinization,
when HT29 microcolonies contained about 30 cells.
Cloning of HT29 cells
Aliquots, 200 l each, of trypsinized HT29 cells diluted
to the concentration of 4 cells/ml were distributed into
96-well microtiter plates. Each well was inspected 4 h
later to determine the quantity of HT29 cells present.
Wells containing single cells were then inspected every
4 days for formation of microcolonies. Subcultures orig-
inating from a single microcolony per well and producing
p24gag antigen were expanded further.
Construction of chimeric viruses
All anotated positions of oligonucleotide primers and
probes in this work correspond to the sequence of HIV-1
NDK (Spire et al., 1989). Full-length env-coding regions
were amplified by PCR from genomic DNA using polA1
primer, 5-TGCCCACACTAATGATGTGAAACAATTA-3 (nt
3617–3646, sense) and nef primer 5-TTTCCAGGTCTC-
GAGATACTGCTCC-3 (nt 8847–8871, antisense). PCR
products were digested by EcoRI5734 and XhoI8857, cloned
into pBluescript, and subcloned by homologous recom-
bination into the plasmid pNL4-3 to obtain a complete
HIV-1 provirus sequence. To construct chimeras be-
tween envelope glycoproteins of prototype and intestinal
cell-adapted virus, EcoRI5734-XhoI8857, fragments of both
viruses cloned in pBluescript were recombined by recip-
rocal exchange of genetic material using conservative
EcoRI5734, BglII7016, ClaI7120, PpuMI7302, BglII8033, PpuMI8359,
and XhoI8857 sites. Recombined EcoRI5734-XhoI8857 frag-
ments were then subcloned by homologous recombina-
tion into the plasmid pNL4-3. Recombinant viruses were
obtained by transfection of plasmid DNA into HeLa cells
facilitated by FuGENE 6 transfection reagent (Roche Inc.,
Paris) and filtration of the cell-free supernatant by a
0.22-m filter. The clones and PCR products were se-
quenced by an automated sequencer (Genome Express
SA, Grenoble). Sequence analysis was performed by
DNAsis program.
Detection of extension of V1/V2 region in HIV-1
NDKPBL stock
Phenol-chloroform-extracted genomic DNA from non-
cloned HIV-1 NDKPBL infected PBL was amplified using
primers polA1 (sense) and nef (antisense) (Sanchez et
al., 1997) followed by nested PCR using primer pairs v2
5-ATATAACTACAGCACTAA-3 (nt 6272–6228, sense),
ron1 5-AATTTCTGGGTCCCCTCCTGAGGA-3 (nt 8836–
8859, antisense) and pa 5-GAAAGAGCAGAAGACAG-
TGG-3 (nt 5737–5756, sense), v2 5-TATCCCTTAGTG-
CTGTAG-3 (nt 6272–6228, antisense).
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